UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation

PloS one, 2015-12, Vol.10 (12), p.e0144314-e0144314

2015

Link zum Volltext

Verfügbarkeit prüfen

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases

Internal and emergency medicine, 2020-08, Vol.15 (5), p.783-786

2020

Link zum Volltext

Verfügbarkeit prüfen

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

The Lancet (British edition), 1996-08, Vol.348 (9025), p.423-428

1996

Link zum Volltext

Verfügbarkeit prüfen

Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL1

Clinical chemistry and laboratory medicine, 2012-12, Vol.50 (12), p.2137-2140

2012

Link zum Volltext

Verfügbarkeit prüfen

Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL

Blood transfusion = Trasfusione del sangue, 2018-09, Vol.16 (5), p.462-470

2018

Link zum Volltext

Verfügbarkeit prüfen

MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study

Seminars in thrombosis and hemostasis, 2021-11, Vol.47 (8), p.982

2021

Link zum Volltext

Verfügbarkeit prüfen

The expert in hemostasis and thrombosis in the Italian health system: role and requirements for a specific clinical and laboratory expertise

Italian journal of medicine, 2013-01, Vol.7 (8S), p.71-73

2013

Link zum Volltext

Verfügbarkeit prüfen

Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL

Clinical chemistry and laboratory medicine, 2012-12, Vol.50 (12), p.2137-2140

2012

Link zum Volltext

Verfügbarkeit prüfen

Direct oral anticoagulants vs non-vitamin K antagonist in atrial fibrillation: A prospective, propensity score adjusted cohort study

European journal of internal medicine, 2019-04, Vol.62, p.9-16

2019

Link zum Volltext

Verfügbarkeit prüfen

Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL 1

Clinical chemistry and laboratory medicine, 2012-12, Vol.50 (12), p.2137-2140

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment)

Haematologica (Roma), 2001-10, Vol.86 (10), p.1060

2001

Link zum Volltext

Verfügbarkeit prüfen

Documento di consenso FCSA, SIMeL, SIBioC e CISMEL sul monitoraggio di laboratorio dei nuovi farmaci anticoagulanti orali

La rivista italiana della medicina di laboratorio, 2013-09, Vol.9 (3), p.131-133

2013

Link zum Volltext

Verfügbarkeit prüfen

Identificazione e ruolo dell’Esperto in Emostasi e Trombosi nel Sistema Sanitario Nazionale Italiano

La rivista italiana della medicina di laboratorio, 2013-09, Vol.9 (3), p.134-142

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: A multicenter, randomized, double-blind study

Thrombosis research, 2007-01, Vol.119 (1), p.85-91

2007

Link zum Volltext

Verfügbarkeit prüfen

Effects of subacute treatment with benzopyranopyrimidines in hemostasis and experimental thrombosis in mice

Life sciences (1973), 2004-02, Vol.74 (15), p.1851-1859

2004

Link zum Volltext

Verfügbarkeit prüfen

Intron 1 factor VIII gene inversion in a population of Italian hemophilia A patients

Blood, 2002-11, Vol.100 (9), p.3432-3432

2002

Link zum Volltext

Verfügbarkeit prüfen

Intron factor VIII gene inversion in a population of Italian hemophilia A patients

Blood, 2002-11, Vol.100 (9), p.3432

2002

Link zum Volltext

Verfügbarkeit prüfen

An acquired hemorrhagic disorder of fibrin crosslinking due to LgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide

American journal of hematology, 1995-01, Vol.48 (1), p.34-39

1995

Link zum Volltext

Verfügbarkeit prüfen

Seasonal variation of oral anticoagulant effect

Thrombosis and haemostasis, 1994-06, Vol.71 (6), p.802

1994

Link zum Volltext

Verfügbarkeit prüfen

Comparison of two automated coagulometers and the manual tilt-tube method for the determination of prothrombin time

American journal of clinical pathology, 1989-09, Vol.92 (3), p.321-328

1989

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Activity of a Low Molecular Weight Dermatan Sulfate (Desmin) in Healthy Volunteers

Seminars in thrombosis and hemostasis, 1994-01, Vol.20 (3), p.259-265

1994

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of Desmin (low molecular weight Dermatan sulphate) in healthy volunteers following intravenous bolus administration of different dosages (200, 400, 800 mg)

Thrombosis research, 1995-08, Vol.79 (3), p.249-260

1995

Link zum Volltext

Verfügbarkeit prüfen

PHARMACOLOGY OF A NEW LOW MOLECULAR WEIGHT DERMATAN SULPHATE (DESMIN) IN HEALTHY VOLUNTEERS: REPEATED DAILY INTRAMUSCULAR ADMINISTRATION OF 400 mg FOR A WEEK

Thrombosis research, 1996-07, Vol.83 (1), p.103-109

1996

Link zum Volltext

Verfügbarkeit prüfen

Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study

Archives of internal medicine (1960), 2000-02, Vol.160 (4), p.470

2000

Link zum Volltext

Verfügbarkeit prüfen

Variation in Hemostatic Parameters after Intra-Arterial and Intravenous Administration of Iodinated Contrast Media

Investigative radiology, 1992-12, Vol.27 (12), p.1025-1029

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(34)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(23)
Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Female
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Hematology
(11)
Male
(10)
Pharmacology. Drug Treatments
(9)
Adult
(7)
Anticoagulants - Administration & Dosage
(7)
Blood. Blood Coagulation. Reticuloendothelial System
(7)
Cardiovascular System & Cardiology
(7)
Peripheral Vascular Disease
(7)
Aged
(5)
General & Internal Medicine
(5)
Medicine, General & Internal
(5)
Administration, Oral
(4)
Animals
(4)
Anticoagulants
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)

Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL1

Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL

MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study

The expert in hemostasis and thrombosis in the Italian health system: role and requirements for a specific clinical and laboratory expertise

Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL

Direct oral anticoagulants vs non-vitamin K antagonist in atrial fibrillation: A prospective, propensity score adjusted cohort study

Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL 1

Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment)

Documento di consenso FCSA, SIMeL, SIBioC e CISMEL sul monitoraggio di laboratorio dei nuovi farmaci anticoagulanti orali

Identificazione e ruolo dell’Esperto in Emostasi e Trombosi nel Sistema Sanitario Nazionale Italiano

Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: A multicenter, randomized, double-blind study

Effects of subacute treatment with benzopyranopyrimidines in hemostasis and experimental thrombosis in mice

Intron 1 factor VIII gene inversion in a population of Italian hemophilia A patients

Intron factor VIII gene inversion in a population of Italian hemophilia A patients

An acquired hemorrhagic disorder of fibrin crosslinking due to LgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide

Seasonal variation of oral anticoagulant effect

Comparison of two automated coagulometers and the manual tilt-tube method for the determination of prothrombin time

Pharmacological Activity of a Low Molecular Weight Dermatan Sulfate (Desmin) in Healthy Volunteers

Pharmacology of Desmin (low molecular weight Dermatan sulphate) in healthy volunteers following intravenous bolus administration of different dosages (200, 400, 800 mg)

PHARMACOLOGY OF A NEW LOW MOLECULAR WEIGHT DERMATAN SULPHATE (DESMIN) IN HEALTHY VOLUNTEERS: REPEATED DAILY INTRAMUSCULAR ADMINISTRATION OF 400 mg FOR A WEEK

Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study

Variation in Hemostatic Parameters after Intra-Arterial and Intravenous Administration of Iodinated Contrast Media

Suchergebnisse filtern